← Open Payments lookup

AIZZEL TRIEU: Open Payments

NPI 1689214074 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,710 in 168 payments from 13 companies in 2025. Trend: 2023 $2,569 · 2024 $3,269 · 2025 $3,710

Food & beverage: $3,601Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.22$576
Alkermes, Inc.27$536
Otsuka America Pharmaceutical, Inc.20$513
Axsome Therapeutics, Inc.12$372
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$368
E.R. Squibb & Sons, L.L.C.9$329
Lundbeck LLC12$244
Vanda Pharmaceuticals Inc.15$236
Neurocrine BioSciences, Inc.12$204
ABBVIE INC.16$195

Products named: REXULTI, ARISTADA, Auvelity, CAPLYTA, COBENFY, AUSTEDO XR, UZEDY, INGREZZA.

Industry payments across CA — which companies pay providers there.